Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Urol Oncol. 2014 Jul 11;33(9):388.e19–388.e25. doi: 10.1016/j.urolonc.2014.06.004

Table 1. ALC and Patient Characteristics.

ALC ALC <1.3

N % Mean Median Min Max p-value N % p-value

Overall 192 1.6 1.6 0.5 3.5 56 29.2
PRCC type 0.420 0.730
 I 86 44.8 1.7 1.6 0.5 2.9 24 27.9
 II 106 55.2 1.6 1.5 0.7 3.5 32 30.2
T stage 0.016 0.002
 T1 128 66.7 1.6 1.7 0.5 3.5 27 21.1
 T2 25 13 1.4 1.5 0.8 2.9 9 36.0
 T3 36 18.8 1.3 1.4 0.7 2.7 18 50.0
 T4 3 1.6 1.0 1.3 0.9 2 2 66.7
N stage 0.120 0.580
 N0 175 91.2 1.6 1.7 0.5 3.5 50 28.6
 N1 17 8.8 1.4 1.4 0.8 2.5 6 35.3
M stage 0.082 0.790
 M0 174 90.6 1.6 1.7 0.5 3.5 50 28.7
 M1 18 9.4 1.4 1.4 0.8 2.5 6 33.3
TNM stage 0.012 0.005
 I 123 64.1 1.6 1.7 0.5 3.5 26 21.1
 II 24 12.5 1.4 1.5 0.8 2.9 9 37.5
 III 26 13.5 1.2 1.4 0.7 2.7 14 53.9
 IV 19 9.9 1.4 1.4 0.8 2.5 7 36.4
Age at surgery 0.001 0.073
 <60 75 39.1 1.7 1.8 0.6 3.5 16 21.3
 >60 117 60.9 1.5 1.5 0.5 2.9 40 34.2
Gender 0.035 0.471
 F 49 25.5 1.7 1.8 0.6 3 12 24.5
 M 143 74.5 1.5 1.6 0.5 3.5 44 30.8
CCI (weighted) 0.017 0.004
 <2 104 54.2 1.7 1.6 0.5 3.5 21 20.2
 >2 88 45.8 1.5 1.4 0.7 3.0 35 39.8
Smoking History 0.052 0.631
 Never 79 41.2 1.5 1.5 0.5 2.9 25 31.7
 Ever 113 58.8 1.7 1.7 0.7 3.5 31 27.4